💥 Gate Square Event: #PostToWinCGN 💥
Post original content on Gate Square related to CGN, Launchpool, or CandyDrop, and get a chance to share 1,333 CGN rewards!
📅 Event Period: Oct 24, 2025, 10:00 – Nov 4, 2025, 16:00 UTC
📌 Related Campaigns:
Launchpool 👉 https://www.gate.com/announcements/article/47771
CandyDrop 👉 https://www.gate.com/announcements/article/47763
📌 How to Participate:
1️⃣ Post original content related to CGN or one of the above campaigns (Launchpool / CandyDrop).
2️⃣ Content must be at least 80 words.
3️⃣ Add the hashtag #PostToWinCGN
4️⃣ Include a screenshot s
Turn Therapeutics' shares jumped about 15% this week. Investors seemed excited after the company's talk at a big healthcare event.
The CEO boasted about their new drug. It's for a rare genetic thing. Just got approved in the US and Europe. Could be worth over $1.5 billion worldwide. Pretty big deal.
They're feeling good about money. The new drug might help them break even soon. No need to beg for cash, it seems. That's kind of a relief for investors.
The drug's just hitting the market. Early numbers coming soon. Everyone's curious how it's selling. Will patients actually use it? We'll see.
Turn Therapeutics is all about rare diseases. They're doing some cool stuff. Lots of people think they might be the next big thing in biotech. But who knows, right? It's not entirely clear how it'll all play out.